Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats

Abstract

BACKGROUND E-52862 (S1RA, 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]-morpholine), a novel selective sigma 1 receptor (σ1R) antagonist, has demonstrated efficacy in nociceptive and neuropathic pain models. Our aim was to test if σ1R blockade with E-52862 may modify the signs of neuropathy in Zucker diabetic fatty (ZDF) rats, a type 2… (More)
DOI: 10.1002/ejp.897

6 Figures and Tables

Topics

  • Presentations referencing similar topics